165 related articles for article (PubMed ID: 38577058)
1. Safety and tolerability of topical trametinib in rosacea: Results from a phase I clinical trial.
Wladis EJ; Busingye J; Saavedra LK; Murdico A; Adam AP
Skin Health Dis; 2024 Apr; 4(2):e346. PubMed ID: 38577058
[TBL] [Abstract][Full Text] [Related]
2. A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors.
Grilley-Olson JE; Bedard PL; Fasolo A; Cornfeld M; Cartee L; Razak AR; Stayner LA; Wu Y; Greenwood R; Singh R; Lee CB; Bendell J; Burris HA; Del Conte G; Sessa C; Infante JR
Invest New Drugs; 2016 Dec; 34(6):740-749. PubMed ID: 27450049
[TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in treatment of rosacea.
Tan JK; Girard C; Krol A; Murray HE; Papp KA; Poulin Y; Chin DA; Jeandupeux D
J Cutan Med Surg; 2002; 6(6):529-34. PubMed ID: 12001006
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma.
Tolcher AW; Patnaik A; Papadopoulos KP; Rasco DW; Becerra CR; Allred AJ; Orford K; Aktan G; Ferron-Brady G; Ibrahim N; Gauvin J; Motwani M; Cornfeld M
Cancer Chemother Pharmacol; 2015 Jan; 75(1):183-9. PubMed ID: 25417902
[TBL] [Abstract][Full Text] [Related]
5. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
Karabulut AA; Izol Serel B; Eksioglu HM
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
[TBL] [Abstract][Full Text] [Related]
6. Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea.
Kuang AW; DuBois J; Attar M; Ahluwalia G
J Drugs Dermatol; 2018 Feb; 17(2):213-220. PubMed ID: 29462230
[TBL] [Abstract][Full Text] [Related]
7. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
[TBL] [Abstract][Full Text] [Related]
8. Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.
Tolcher AW; Kurzrock R; Valero V; Gonzalez R; Heist RS; Tan AR; Means-Powell J; Werner TL; Becerra C; Wang C; Leonowens C; Kalyana-Sundaram S; Kleha JF; Gauvin J; D'Amelio AM; Ellis C; Ibrahim N; Yan L
Cancer Chemother Pharmacol; 2020 Apr; 85(4):673-683. PubMed ID: 32062691
[TBL] [Abstract][Full Text] [Related]
9. Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea.
Rigopoulos D; Kalogeromitros D; Gregoriou S; Pacouret JM; Koch C; Fisher N; Bachmann K; Brown M; Schwarz E; Camel E; Katsambas A
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):564-8. PubMed ID: 16164709
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF
Schadendorf D; Hauschild A; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Lesimple T; Plummer R; Schachter J; Dasgupta K; Manson S; Koruth R; Mookerjee B; Kefford R; Dummer R; Kirkwood JM; Long GV
Lancet Oncol; 2019 May; 20(5):701-710. PubMed ID: 30928620
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
13. Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Infante JR; Fecher LA; Falchook GS; Nallapareddy S; Gordon MS; Becerra C; DeMarini DJ; Cox DS; Xu Y; Morris SR; Peddareddigari VG; Le NT; Hart L; Bendell JC; Eckhardt G; Kurzrock R; Flaherty K; Burris HA; Messersmith WA
Lancet Oncol; 2012 Aug; 13(8):773-81. PubMed ID: 22805291
[TBL] [Abstract][Full Text] [Related]
14. A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors.
Tolcher AW; Bendell JC; Papadopoulos KP; Burris HA; Patnaik A; Jones SF; Rasco D; Cox DS; Durante M; Bellew KM; Park J; Le NT; Infante JR
Ann Oncol; 2015 Jan; 26(1):58-64. PubMed ID: 25344362
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled, multiple-dose study of the safety, tolerability and pharmacokinetics of benvitimod, a candidate drug for the treatment of psoriasis.
Zhao L; Chen X; Cai L; Zhang C; Wang Q; Jing S; Chen G; Li J; Zhang J; Fang Y
J Clin Pharm Ther; 2014 Aug; 39(4):418-23. PubMed ID: 24673513
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Rosacea: Results From Two Phase III, Randomized, Vehicle-Controlled Trials.
Bhatia ND; Werschler WP; Baldwin H; Sugarman J; Green LJ; Levy-Hacham O; Nov O; Ram V; Stein Gold L
J Clin Aesthet Dermatol; 2023 Aug; 16(8):34-40. PubMed ID: 37636253
[TBL] [Abstract][Full Text] [Related]
17. Interventions for rosacea.
van Zuuren EJ; Fedorowicz Z; Carter B; van der Linden MM; Charland L
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD003262. PubMed ID: 25919144
[TBL] [Abstract][Full Text] [Related]
18. Effects of a facial cream containing the minor alkaloid anatabine on improving the appearance of the skin in mild to moderate rosacea: an open-label case series study.
Lanier RK; Cohen AE; Weinkle SH
Case Rep Dermatol; 2013; 5(3):347-56. PubMed ID: 24348385
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States.
Taieb A; Stein Gold L; Feldman SR; Dansk V; Bertranou E
J Manag Care Spec Pharm; 2016 Jun; 22(6):654-65. PubMed ID: 27231793
[TBL] [Abstract][Full Text] [Related]
20. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
